Haaartland

Login
Innovative Type 1 Diabetes Approach Licensed to Encellin

inBrighter #Type1diabetes

Innovative Type 1 Diabetes Approach Licensed to Encellin

Source: UC San Francisco

Bo

Bo

Your sidekick
Sweden

Bo
Your sidekick

  • 0

Encellin, a San Francisco-based biotechnology company, has obtained exclusive worldwide rights from UC San Francisco for a proprietary cell encapsulation technology aimed at improving physicians' ability to perform cell transplants without the need for immunosuppressive drugs.

View original